A-Team Insight Blogs

BIS Publishes New Guidance on CDE Governance

Share article

The Bank of International Settlements (BIS), parent of the Basel Committee, has published new guidance on global governance arrangements to harmonise the usage and reporting of critical OTC derivatives data elements (CDE).

The new guidelines follow the decision taken by the G20 back in 2009 requiring all OTC derivatives transactions to be reported to trade repositories (TRs) in order to improve transparency, mitigate systemic risk and prevent market abuse. However, in order to aggregate that data to give regulators a comprehensive overview of the trading landscape, the disparate data elements must be standardised and harmonised.

In October 2019 the Committee on Payments and Market infrastructures (CPMI) and the International Organization of Securities Commissions (IOSCO), under the BIS banner, published a new report identifying key criteria, functions and bodies for the governance arrangements for CDE, excluding the Unique Transaction Identifier (UTI) and the Unique Product Identifier (UPI).

The new governance covers three broad areas: maintenance, oversight, and implementation.

In coordination with the Financial Stability Board (FSB), in its capacity as the international body in charge of defining governance arrangements for the UTI and UPI,  the report concludes that the Legal Entity Identifier Regulatory Oversight Committee is best positioned to take on the role of the international governance body for critical data elements by mid-2020, subject to some necessary adjustments to its own governance. In the interim, the FSB will perform this role.

CPMI and IOSCO also recommend that jurisdictions take steps to implement the governance arrangements across jurisdictions within three years from the publication of the report.

In 2014 the FSB conducted a Feasibility Study on approaches to aggregate OTC derivatives data, and asked global guidance based on the results. This report is the final part of CPMI and IOSCO’s response to that mandate, and complements the previously published Technical guidance on harmonisation of the UTI, the Technical guidance on harmonisation of the UPI and the Technical guidance on harmonisation of critical OTC derivatives data elements (other than UTI and UPI).

Leave a comment

Your email address will not be published. Required fields are marked *

*

Related content

WEBINAR

Recorded Webinar: How to leverage the LIBOR transition to improve your data management game

The transition away from LIBOR (London Interbank Offered Rate) is well underway, but there remains considerable ambiguity around how the final stages will be executed – especially with regards to benchmark replacements in markets outside the UK. What are the options, where are the uncertainties and what stage have firms reached in their preparations? The...

BLOG

VIDEO: How To Determine The True Value of Data, with Rocky Martinez

The A-Team Group Data Management Summit is fast-approaching, and with a spotlight on how to improve operational efficiency and enhance revenue opportunities through data, identifying value is a key topic for 2020. We are delighted to welcome Rocky Martinez, Chief Technology Officer at SmartStream RDU, to give us a sneak peek into his keynote speech...

EVENT

Data Management Summit Boston

As investment management firms take on more responsibility and control over core operational functions, A-Team has seen demand for a more buy-side oriented event focused on data and data management. The inaugural DMS Boston will take place in June 2020, and will focus on topics of interest to buy-side practitioners.

GUIDE

Regulatory Data Handbook – Fourth Edition

Need to know all the essentials about the regulations impacting data management? Welcome to the Fourth edition of our A-Team Regulatory Data Handbook which provides all the essentials about regulations impacting data management. A-Team’s series of Regulatory Data Handbooks are a great way to see at-a-glance: All the regulations that are impacting data management today A...